Halting COVID-19 trial shows good oversight, says Wits' Prof Madhi

  • 📰 ewnupdates
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 53%

South Africa Headlines News

South Africa Latest News,South Africa Headlines

As part of regulatory procedure, further vaccination of participants enrolled in the study has been halted after a volunteer in the UK fell ill.

CAPE TOWN - A Wits University medical expert said that halting the country’s first coronavirus vaccine efficacy trial was in fact evidence of sound clinical practice.

Wits is collaborating with Oxford University, along with a biopharmaceutical company, to develop a vaccine. The Independent Data and Safety Monitoring Committee has recommended further vaccination of candidates be temporarily halted while it investigates the UK case which saw a trial participant fall ill.Professor Shabir Madhi, executive director of the vaccines and infectious diseases analytics research unit, said that pausing vaccination demonstrated the rigour of the oversight process.

"Assessing the safety of the vaccine is the reason why studies such as these are essential in South Africa before the widespread use of the vaccine."Download the EWN app to your iOS or Android device.

Source: Law Daily Report (lawdailyreport.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 30. in ZA

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19 LIVE UPDATES | How these Covid-19 modellers got the death toll rightCovid-19 live updates.
Source: TimesLIVE - 🏆 28. / 59 Read more »

Oxford puts leading Covid-19 vaccine trial on hold over safety concernAstraZeneca Plc on Tuesday said it has paused a late-stage trial of one of the leading Covid-19 vaccine candidates after an unexplained illness in a study participant.
Source: SowetanLIVE - 🏆 13. / 63 Read more »

Newsdeck: AstraZeneca puts leading COVID-19 vaccine trial on hold over safety concernSept 8 (Reuters) - AstraZeneca Plc on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.
Source: dailymaverick - 🏆 3. / 84 Read more »

Covid-19 shows need to optimise scarce nursing resourcesThe COVID_19 pandemic has highlighted the need for more training of nurses, Life Healthcare group nursing and quality executive Dr Sharon Vasuthevan said.
Source: IOL - 🏆 46. / 51 Read more »

Oxford's Covid-19 vaccine trial paused after 'unexplained illness'The vaccine has been described as probably the world's leading candidate and the most advanced in terms of development.
Source: TimesLIVE - 🏆 28. / 59 Read more »

COVID-19 vaccine trial on hold after unexplained illnessBritain's Health Secretary says pharmaceutical company AstraZeneca has paused its COVID-19 vaccine trial for a safety review.
Source: eNCA - 🏆 49. / 51 Read more »